You have now been acquainted to the access-excess dilemma, which we would like you to further reflect upon.
Reflection and analysis
1. Please try to identify plausible explanations to why antibiotics are used in excess in the human health sector worldwide.
- Are the mechanisms the same in high-income and low-income countries?
- In communities and hospitals?
- What actions do you think must be taken to improve the situation and slow down the antibiotic resistance development?
2. Please reflect upon what importance the price and profitability of antibiotics have for patients and providers.
- How do you think access to antibiotics and excessive use are affected by pricing?
- What do you think the consequences will be if antibiotics are cheaper than a health-care visit or relevant clinical diagnostics?
- What happens if antibiotics are not affordable?
3. Please consider what actions you think should be taken to improve access to antibiotics for all in need.
- What actors and stakeholders do you think should lead this work on national and global level? Why?
© Uppsala University
More from "Part 3"
- Nearly empty pipeline
- Why don’t we simply develop new antibiotics?
- Alternatives to antibiotics
- New business models addressing antibiotic resistance
- How can we tackle this rather critical situation?
- Innovation of antibiotics
- Securing access while reducing excess
- Access not excess – rational use of antibiotics
- Who is responsible?
- Test your understanding III
- Reflection and analysis: the access-excess dilemma
- End of part 3